Transforming Brain Cancer Care
Every brain cancer patient is unique, and so is every brain tumor.
Neuro-oncology teams need new tools and insights to advance the state of care.
At Neosoma, our mission is to help clinicians improve outcomes by providing novel disease insights to physicians and clinical trials through innovative AI technology.
Brain Tumors Are Complex
Every Treatment Decision is Based on MRI Interpretation
Care is a multi-disciplinary process with significant limitations to treatment.
The Answers Are Hidden Within Every MRI
Critical data that is needed to improve treatment and outcomes exists inside every slice of each MRI.
Without Advanced AI Technology, These Insights will Never Be Accessed
Even the most expert clinicians are forced to use subjective judgement when assessing a brain tumor MRI.
Neosoma Uncovers Transformative Disease Insights
from Brain Tumor MRIs
Comprehensive Neuro-Oncology
SaaS Solution
Patented, Validated,
FDA Cleared
AI-Powered 3-D Tumor Analysis
Longitudinal Disease Assessment
Centralized Document Management
Virtual Tumor Board Sessions
Patient Notes,
Auditing,
Session Attendance
Neuro-Radiologist
Neuro-Surgeon
Neuro-Oncologist
Radiation Oncologist
Medical Oncologist
A unified, clinican-validated software platform for the entire neuro-oncology team, combining tumor board workflow with multiple disease-specific AI-driven analysis modules.
Seamless Integration; Deep Insights
Routinely-Acquired MRI Sequences
T1-pre
T1-post
T2
FLAIR
Longitudinal
Disease Insights
Interoperability with
Existing Systems
Centralized
Decisioning Platform
Neosoma Benefits Clinicians, Hospitals,
Patients, and Clinical Trials
Clinicians and Hospitals
We enable better clinical decisions, thereby raising the standard of care.
Hospitals drive increased patient volume and revenue, while reducing unnecessary costs.
Patients
Increased engagement with your physicians, better understanding of your disease and treatment protocol, and greater confidence in tumor change and response to treatment.
Clinical Trials
Increase success and efficiency of clinical research and development through greater speed, accuracy, precision, and consistency of key endpoints, including RANO.
See An Interactive Example Of A
High-Grade Glioma Segmentation
Use mouse wheel to scroll through slices.
Current slice:
In Clinicians' Own Words
“Neosoma avoids interruptions in care, unnecessary surgeries, and unnecessary changes in therapy. The entire team benefits from centralized information, more efficient communication, and treatment protocols tailored to each specific patient.”
Joseph Landolfi, D.O.
Chief Medical Officer, JFK Hackensack Meridian Health
